RxDoctor Payments Data

Vyacheslav Isakov, MD

Family Medicine · Mentor, OHNPI 1407826803

Payments from drug & device makers

$1,421in general payments, 2019–2025

Across 97 payments — averaging $14.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$281
  • Lilly USA, LLC$245
  • AbbVie$160
  • AstraZeneca$155
  • Novo Nordisk$91
  • Johnson & Johnson$68
  • plus $421 from 12 others

What the payments were for

  • Food & beverage$1,41399%
  • Education$81%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,421 in reported general payments places this provider in the 65th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$90,126
Medicare patients
166
Services billed
1,076

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban138$101,700
TrulicityDulaglutide80$95,871
JardianceEmpagliflozin110$77,029
OzempicSemaglutide55$63,939
CreonLipase/Protease/Amylase19$59,985
LinzessLinaclotide48$38,909
JanuviaSitagliptin Phosphate54$38,049
MyrbetriqMirabegron62$28,981
MounjaroTirzepatide24$26,246
XareltoRivaroxaban27$21,171
FarxigaDapagliflozin Propanediol14$17,993
TradjentaLinagliptin11$16,360
Breztri AerosphereBudesonide/Glycopyr/Formoterol20$14,082
Repatha SureclickEvolocumab13$7,346
Breo ElliptaFluticasone/Vilanterol11$6,709

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$245$122,117104 claims
PfizerEliquis$281$101,700138 claims
AbbVieCreon, Linzess$160$98,89367 claims
Boehringer IngelheimJardiance, Tradjenta$49$93,389121 claims
Novo NordiskOzempic$91$63,93955 claims
MerckJanuvia$39$38,04954 claims
AstraZenecaFarxiga, Breztri Aerosphere$155$32,07534 claims
Astellas Pharma US IncMyrbetriq$27$28,98162 claims
Johnson & JohnsonXarelto$68$21,17127 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Mentor

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →